$SRNE News Article - Sorrento Announces Dosing of
Post# of 114
(Total Views: 293)
Posted On: 07/21/2021 11:26:00 AM
$SRNE News Article - Sorrento Announces Dosing of COVID-19 Patients in Phase 2 Clinical Trial for COVIDROPS, a Highly Potent Neutralizing Antibody Against SARS-CoV-2 Including Delta and Alpha Variants of Concern, in an At-Home Outpatient Setting in United Kingdom https://marketwirenews.com/news-releases/sorr...13650.html
(0)
(0)Sorrento Therapeutics Inc. (SRNE) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼